CClinicalTrials.gg
CompletedNCT02695927Updated May 11, 2018

Rehabilitation Glasses for the Treatment of Hemispatial Neglect

A Phase 1 interventional study of Computer rehabilitation glasses in Hemispatial Neglect, sponsored by Chun Lim. Completed at 1 site in United States. Open to participants aged 21 Years to 85 Years. Per ClinicalTrials.gov, last updated 2018-05-11.

Sponsored by Chun Lim · Phase 1, Interventional, and Treatment

Phase
Phase 1
Study type
Interventional
Enrollment
38
Allocation
Randomized
Ages
21 Years to 85 Years
Sex
All
01

Study summary

This project is designed to test a lightweight, portable, computerized pair of glasses that will help reduce some of the cognitive deficits seen in patients who have suffered damage to their right cerebral hemisphere.

Read the detailed description

Hemispatial neglect is the inability or failure to attend and respond to the left side of space. Patients suffering right cerebral hemispheric damage from stroke or traumatic brain injury frequently suffer neglect and will ignore all information located in the left side of space. Currently there is no effective rehabilitation technique to treat neglect and many of these patients have severe long-term disability. The goal of this project is to determine whether a prototypical pair of rehabilitation glasses can reduce the symptoms of hemispatial neglect.

02

Conditions studied

  • Hemispatial Neglect

Browse trials for

03

In context

Perceptual Disorders

92 studies on the registry are indexed under Perceptual Disorders; 23 are open to participants now.

This study's enrollment of 38 is above the median of 30 across 69 interventional studies indexed under Perceptual Disorders.

Browse Perceptual Disorders studies →

Lead sponsor

This is the only study on the registry with Chun Lim as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Presence of hemispatial neglect as defined by Behavioral Inattention Test score of 129 or worse (maximum score 146).

Exclusion criteria

Exclusion Criteria:

  • Presence of aphasia at time of testing,
  • Recent seizures
  • Major psychiatric illness
  • Prior unrelated neurological disease
05

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
38 participants (actual)

Study arms

  • Experimental
    Chronic

    Crossover study on the benefits of computer rehabilitation glasses on chronic sufferers of hemispatial neglect

    Device: Computer rehabilitation glasses

  • Experimental
    Acute

    Randomized, controlled study on the benefits of computer rehabilitation glasses on acute sufferers of hemispatial neglect

    Device: Computer rehabilitation glasses

  • Experimental
    Optimization

    Study to identify optimal operating parameters of computer rehabilitation glasses

    Device: Computer rehabilitation glasses

  • Active comparator
    Duration

    Study to determine duration of effect of computer rehabilitation glasses

    Device: Computer rehabilitation glasses

Interventions

  • DeviceComputer rehabilitation glasses
06

What researchers measure

Primary outcomes

  1. Improvement of patient's hemispatial neglect scores

    Behavioral Inattention Test

    Time frame: 60 days

07

Study locations

1 site
  • Beth Israel Deaconess Medical Center
    Boston, Massachusetts 02215, United States
08

References and documents

Publications

  • Longley V, Hazelton C, Heal C, Pollock A, Woodward-Nutt K, Mitchell C, Pobric G, Vail A, Bowen A. Non-pharmacological interventions for spatial neglect or inattention following stroke and other non-progressive brain injury. Cochrane Database Syst Rev. 2021 Jul 1;7(7):CD003586. doi: 10.1002/14651858.CD003586.pub4. PubMed 34196963 ↗

Individual participant data

Plan to share: Yes — IPD will be shared upon publication of the data. Other researchers can contact PI to request this data.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 11, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02695927
Lead sponsor
Chun Lim
Responsible party
Chun Lim (Physician, Beth Israel Deaconess Medical Center) — Sponsor-investigator
First posted
Mar 1, 2016
Start date
Mar 2009
Primary completion
Mar 26, 2018
Completion
Mar 26, 2018
Last update
May 11, 2018

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion